At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 16 enrolled
Drug / intervention
Metformin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Clinical Trial to Evaluate the Effect of Nilotinib on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Male Adults
In Brief
A Phase 1 clinical trial evaluating Metformin and Metformin + Nilotinib for Healthy. Completed, enrolled 16 participants across 1 site.
Detailed Summary
The aim of the study is to evaluate the effect of nilotinib on the pharmacokinetics and pharmacodynamics of metformin in healthy male adults
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesSouth Korea
Collaborators--
Timeline
Phase 1CompletedFinished
202120222023202420252026
First PostedJun 2020
Enrollment StartJul 2020
Primary CompletionSep 2020
TodayJul 2026
First PostedJun 26, 2020
Enrollment StartJul 23, 2020
Primary CompletionSep 7, 2020
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 6.0 years ago
Interventions
Metformindrug
Single administration of metformin
Metformin + Nilotinibdrug
Coadministration of metformin and nilotinib